Chimeric Antigen Receptors T Cell Therapy in Solid Tumor: Challenges and Clinical Applications
Hamid Reza Mirzaei(The University of Texas MD Anderson Cancer Center), Behnam Badie(City Of Hope National Medical Center)
Cited by 216
Related Papers
Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy
|New England Journal of Medicine|2016|1.8k
Bioactivity and Safety of IL13Rα2-Redirected Chimeric Antigen Receptor CD8+ T Cells in Patients with Recurrent Glioblastoma
|Clinical Cancer Research|2015|754
CRISPR Screening of CAR T Cells and Cancer Stem Cells Reveals Critical Dependencies for Cell-Based Therapies
|Cancer Discovery|2020|177
Interferon-γ Induces Apoptosis and Augments the Expression of Fas and Fas Ligand by Microglia in Vitro
|Experimental Neurology|2000|78